EL
REGN icon

EMFO LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

EMFO LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$9.46K Hold
9
– – 0.01% 228
2024
Q1 		$8.66K Hold
9
– – 0.01% 236
2023
Q4 		$7.91K Hold
9
– – 0.01% 236
2023
Q3 		$7.41K Hold
9
– – 0.01% 249
2023
Q2 		$6.47K Hold
9
– – 0.01% 260
2023
Q1 		$7.4K Hold
9
– – 0.01% 264
2022
Q4 		$6.49K Hold
9
– – 0.01% 253
2022
Q3 		$6K Hold
9
– – 0.01% 284
2022
Q2 		$5K Hold
9
– – 0.01% 296
2022
Q1 		$6K Hold
9
– – 0.01% 301
2021
Q4 		$6K Hold
9
– – 0.01% 312
2021
Q3 		$5K Hold
9
– – ﹤0.01% 326
2021
Q2 		$5K Buy
+9
New +$4.56K ﹤0.01% 310

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EMFO LLC's REGN Position: Q2 2024 in Review

EMFO LLC held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2024 at 9 shares worth $9.46K. The position accounts for 0.01% of the portfolio, ranked #228.

EMFO LLC first reported a position in REGN in Q2 2021 and has held it in 13 quarters since. 1,331 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

  • EMFO LLC held 9 shares of Regeneron Pharmaceuticals worth $9.46K as of Q2 2024.
  • EMFO LLC left its Regeneron Pharmaceuticals share count unchanged in Q2 2024.
  • Regeneron Pharmaceuticals made up 0.01% of EMFO LLC's portfolio in Q2 2024, its #228 holding.
  • EMFO LLC first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
  • 1,331 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.